SCHEMBL22862265

SCHEMBL22862265

CC(C)c1ccc(C(c2ccc(NC(=O)/C=C/C(=O)O)cc2)c2ccc(NC(=O)/C=C/C(=O)O)cc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.62
▸ NMT1 P30419 1/20 0.61
▸ LPAR2 Q9HBW0 2/20 0.60
▸ LPAR3 Q9UBY5 1/20 0.60
▸ MAPT P10636 5/20 0.58
▸ L3MBTL1 Q9Y468 3/20 0.58
▸ THRB P10828 3/20 0.58
▸ TDP2 O95551 1/20 0.58
▸ GAA P10253 1/20 0.58
▸ ALDH1A1 P00352 10/20 0.56
▸ LMNA P02545 1/20 0.56
▸ NR4A1 P22736 1/20 0.56
▸ KDM4E B2RXH2 3/20 0.55
▸ POLB P06746 2/20 0.55
▸ SMN1; SMN2 Q16637 1/20 0.55
▸ MEN1 O00255 2/20 0.53
▸ KMT2A Q03164 2/20 0.53
▸ MAPK1 P28482 1/20 0.50
▸ LPAR1 Q92633 1/20 0.50
▸ THRA P10827 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22862159 0.92 LPAR2 (0.70) NMT1LPAR2LPAR3MAPTL3MBTL1
SCHEMBL22862112 0.92 LPAR2 (0.70) NMT1LPAR2LPAR3MAPTL3MBTL1
SCHEMBL22862256 0.88 NMT1 (0.81) EGFRNMT1LPAR2LPAR3MAPT
SCHEMBL22862074 0.87 LPAR2 (0.80) NMT1LPAR2LPAR3MAPTL3MBTL1
SCHEMBL22862155 0.87 ALDH1A1 (0.68) EGFRNMT1LPAR2LPAR3MAPT
SCHEMBL22862154 0.86 MAPT (0.81) NMT1LPAR2LPAR3MAPTL3MBTL1
SCHEMBL22862124 0.85 NMT1 (0.55) EGFRNMT1LPAR2LPAR3MAPT
SCHEMBL22862139 0.84 NMT1 (0.56) NMT1LPAR2LPAR3MAPTL3MBTL1
SCHEMBL22862048 0.83 ALDH1A1 (0.82) EGFRNMT1LPAR2LPAR3MAPT
SCHEMBL22862113 0.83 LPAR2 (0.61) NMT1LPAR2LPAR3MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210003921-A1 COMPOUND, RESIN, COMPOSITION, AND FILM FORMING MATERIAL FOR LITHOGRAPHY USING THE SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-01-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210003921-A1 COMPOUND, RESIN, COMPOSITION, AND FILM FORMING MATERIAL FOR LITHOGRAPHY USING THE SAME COL1A1, MLLT3, F12 EGFR 2649/4885NMT1 1071/4885LPAR2 869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback